Minimal Residual Disease (MRD) Testing Market: Can Liquid Biopsy...

added blog Health

2026-07-17 08:54:11 -

Minimal Residual Disease (MRD) Testing Market: Can Liquid Biopsy Finally Detect Cancer Before It Comes Back?

The minimal residual disease (MRD) testing market — molecular diagnostic assays that detect trace, sub-clinical cancer cells or circulating tumor DNA remaining after treatment, often months before relapse would be visible on imaging — has moved decisively from research laboratories into routine oncology care, with the Minimal Residual Disease Mrd Testing Market sized in the range of...

0 Comments 0 Shares 260 Views 0 Reviews